Log in

NASDAQ:HCMHUTCHISON CHINA/S News Headlines

$28.58
+0.05 (+0.18 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$28.06
Now: $28.58
$29.35
50-Day Range
$19.94
MA: $23.66
$28.53
52-Week Range
$14.74
Now: $28.58
$29.92
Volume277,200 shs
Average Volume264,860 shs
Market Capitalization$3.81 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.15

Headlines

HUTCHISON CHINA/S (NASDAQ HCM) News Headlines

Source:
DateHeadline
Edison Issues ADR Outlook on Hutchison China MediTech (HCM)Edison Issues ADR Outlook on Hutchison China MediTech (HCM)
finance.yahoo.com - July 6 at 5:53 PM
HUTCHISON CHINA/S to Post FY2021 Earnings of ($1.08) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:HCM)HUTCHISON CHINA/S to Post FY2021 Earnings of ($1.08) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:HCM)
www.americanbankingnews.com - July 3 at 7:16 AM
ValuEngine Lowers HUTCHISON CHINA/S (NASDAQ:HCM) to HoldValuEngine Lowers HUTCHISON CHINA/S (NASDAQ:HCM) to Hold
www.marketbeat.com - July 2 at 2:31 AM
The Hutchison China Meditech share price – where next?The Hutchison China Meditech share price – where next?
uk.finance.yahoo.com - June 26 at 8:53 AM
The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene TherapyThe Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy
finance.yahoo.com - June 25 at 12:26 PM
Chi-Med Announces US$100 Million Equity Investment by General AtlanticChi-Med Announces US$100 Million Equity Investment by General Atlantic
finance.yahoo.com - June 25 at 7:26 AM
HUTCHISON CHINA/S (NASDAQ:HCM) Given Consensus Rating of "Buy" by BrokeragesHUTCHISON CHINA/S (NASDAQ:HCM) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - June 19 at 10:24 AM
Is Hutchison China MediTech Limited (HCM) A Good Stock To Buy?Is Hutchison China MediTech Limited (HCM) A Good Stock To Buy?
finance.yahoo.com - June 12 at 3:14 PM
Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting with the U.S. FDAChi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting with the U.S. FDA
finance.yahoo.com - June 1 at 5:14 AM
Chi-Meds NDA for savolitinib accepted in ChinaChi-Med's NDA for savolitinib accepted in China
seekingalpha.com - May 29 at 7:56 AM
Chi-Med Highlights Clinical Data to be Presented at the Upcoming ASCO20 Virtual Scientific ProgramChi-Med Highlights Clinical Data to be Presented at the Upcoming ASCO20 Virtual Scientific Program
finance.yahoo.com - May 14 at 2:15 AM
Should You Worry About Hutchison China MediTech Limiteds (LON:HCM) CEO Pay?Should You Worry About Hutchison China MediTech Limited's (LON:HCM) CEO Pay?
finance.yahoo.com - April 23 at 4:25 AM
Should You Worry About Hutchison China MediTech Limited's (LON:HCM) CEO Pay?Should You Worry About Hutchison China MediTech Limited's (LON:HCM) CEO Pay?
finance.yahoo.com - April 23 at 4:25 AM
Chi-Med Announces Surufatinib Granted U.S. FDA Fast Track Designations for the Treatment of Both Pancreatic and Non-Pancreatic Neuroendocrine TumorsChi-Med Announces Surufatinib Granted U.S. FDA Fast Track Designations for the Treatment of Both Pancreatic and Non-Pancreatic Neuroendocrine Tumors
finance.yahoo.com - April 17 at 8:42 AM
Hutchison China MediTech (HCM) Upgraded to Buy: What Does It Mean for the Stock?Hutchison China MediTech (HCM) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - March 5 at 2:41 PM
Hutchison China MediTech Limited 2019 Q4 - Results - Earnings Call PresentationHutchison China MediTech Limited 2019 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 3 at 1:07 PM
Chi-Med Reports 2019 Full Year Results and Provides Updates on Key Clinical ProgramsChi-Med Reports 2019 Full Year Results and Provides Updates on Key Clinical Programs
finance.yahoo.com - March 3 at 1:07 PM
Coronavirus May Have Spread in U.S. for Weeks, Gene Sequencing SuggestsCoronavirus May Have Spread in U.S. for Weeks, Gene Sequencing Suggests
www.nytimes.com - March 1 at 6:36 PM
Governor Hutchinson shares preps, plans if Covid-19 comes to ArkansasGovernor Hutchinson shares preps, plans if Covid-19 comes to Arkansas
www.msn.com - March 1 at 8:33 AM
Chi-Med to Announce 2019 Final ResultsChi-Med to Announce 2019 Final Results
finance.yahoo.com - January 31 at 2:46 AM
Hutchison China MediTech Limited Just Released Its Third-Quarter Earnings: Heres What Analysts ThinkHutchison China MediTech Limited Just Released Its Third-Quarter Earnings: Here's What Analysts Think
finance.yahoo.com - January 24 at 2:39 AM
Hutchison China MediTech Limited Just Released Its Third-Quarter Earnings: Here's What Analysts ThinkHutchison China MediTech Limited Just Released Its Third-Quarter Earnings: Here's What Analysts Think
finance.yahoo.com - January 24 at 2:39 AM
Hutchinson China Reports Early Success Of Surufatinib Phase III StudyHutchinson China Reports Early Success Of Surufatinib Phase III Study
www.lse.co.uk - January 20 at 10:45 AM
Chi-Med Initiates a Phase II Trial of Surufatinib in Combination with Tuoyi in Patients with Advanced Solid TumorsChi-Med Initiates a Phase II Trial of Surufatinib in Combination with Tuoyi in Patients with Advanced Solid Tumors
finance.yahoo.com - January 13 at 3:19 AM
Chi-Med to Present at the 38th Annual JP Morgan Healthcare ConferenceChi-Med to Present at the 38th Annual JP Morgan Healthcare Conference
finance.yahoo.com - January 6 at 7:32 AM
Chi-Med Announces Surufatinib Granted FDA Orphan Drug Designation for Pancreatic Neuroendocrine TumorsChi-Med Announces Surufatinib Granted FDA Orphan Drug Designation for Pancreatic Neuroendocrine Tumors
finance.yahoo.com - November 25 at 4:27 AM
How Much Of Hutchison China MediTech Limited (LON:HCM) Do Institutions Own?How Much Of Hutchison China MediTech Limited (LON:HCM) Do Institutions Own?
finance.yahoo.com - November 15 at 2:43 AM
Hedge Funds Have Never Been This Bullish On Hutchison China MediTech Limited (HCM)Hedge Funds Have Never Been This Bullish On Hutchison China MediTech Limited (HCM)
finance.yahoo.com - October 29 at 2:35 PM
Chi-Med highlights publication of Phase II data showing promising efficacy for Savolitinib in MET-amplified gastric cancersChi-Med highlights publication of Phase II data showing promising efficacy for Savolitinib in MET-amplified gastric cancers
finance.yahoo.com - October 17 at 5:50 AM
Hutchison China Expands Tumour Treatment Collaboration With InnoventHutchison China Expands Tumour Treatment Collaboration With Innovent
www.lse.co.uk - October 10 at 8:52 AM
Hutchison China Doses First Patient In HMPL-523 Lymphoma StudyHutchison China Doses First Patient In HMPL-523 Lymphoma Study
www.morningstar.co.uk - October 4 at 7:26 AM
Hutchison China Regulatory NewsHutchison China Regulatory News
www.lse.co.uk - October 4 at 7:26 AM
Edison issues ADR update on Hutchison China MediTech (HCM)Edison issues ADR update on Hutchison China MediTech (HCM)
finance.yahoo.com - August 14 at 10:43 AM
Hutchison China MediTech Limited (HCM) Q2 2019 Earnings Call TranscriptHutchison China MediTech Limited (HCM) Q2 2019 Earnings Call Transcript
finance.yahoo.com - July 30 at 4:48 PM
Credit Suisse initiates coverage of AMC with optimistic outlookCredit Suisse initiates coverage of AMC with optimistic outlook
finance.yahoo.com - July 21 at 3:56 PM
Why Chi-Med Stock Is Tanking TodayWhy Chi-Med Stock Is Tanking Today
finance.yahoo.com - July 6 at 10:23 AM
Prudential Holds 5% Hutchison China Meditech Stake After DealPrudential Holds 5% Hutchison China Meditech Stake After Deal
www.morningstar.co.uk - July 3 at 10:31 AM
Did Hedge Funds Drop The Ball On Hutchison China MediTech Limited (HCM) ?Did Hedge Funds Drop The Ball On Hutchison China MediTech Limited (HCM) ?
finance.yahoo.com - April 26 at 4:00 PM
Hutchison China Meditech (HCM) Shares Cross Below 200 DMAHutchison China Meditech (HCM) Shares Cross Below 200 DMA
www.nasdaq.com - April 25 at 4:23 PM
Chi-Med Files Application to List in Hong Kong and Announces Proposed Global OfferingChi-Med Files Application to List in Hong Kong and Announces Proposed Global Offering
finance.yahoo.com - April 15 at 8:22 AM
Hutchison China Meditech 2018 Loss Widens On New Government PolicyHutchison China Meditech 2018 Loss Widens On New Government Policy
www.morningstar.co.uk - March 11 at 8:19 AM
Chi-Med Reports 2018 Full Year Results and Provides Updates on Key Clinical ProgramsChi-Med Reports 2018 Full Year Results and Provides Updates on Key Clinical Programs
finance.yahoo.com - March 11 at 8:19 AM
Hutchison China Meditech Becomes Oversold (HCM)Hutchison China Meditech Becomes Oversold (HCM)
www.nasdaq.com - January 17 at 12:58 PM
Hutchison China MediTech Ltd. ADRHutchison China MediTech Ltd. ADR
www.barrons.com - December 27 at 10:22 AM
This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.